Volume 1, Issue 2 (2025) builds upon the momentum of our first publication cycle by presenting expanded perspectives and deeper analytical approaches. The contributions in this issue demonstrate steady growth in both submission quality and thematic diversity.
Readers will find discussions that bridge theory and application, encouraging dialogue across disciplines and fostering meaningful academic exchange.
Pharmacovigilance and Reporting of Adverse Drug Reactions
Mohammad Al-Farouq, Michael Tan*, Grace Kim, Carlos Mendez, Fatima Khan
Design of Controlled Release Tablet Formulations
Thomas Schneider, Nguyen Minh, Anna Kowalska, Omar Saeed, Jessica Brown, Yuki Nakamura*
Role of Pharmacogenomics in Personalized Medicine
Nadia Youssef, Daniel Lee, Maria Silva, Ali Rezaei, George Anderson*
Drug–Drug Interactions in Polypharmacy Patients
Budi Santoso, Claire Dubois, Yusuf Ibrahim, Mei Ling*, Lucas Rossi, Sofia Garcia
Quality Control Testing of Pharmaceutical Products
Arjun Menon, Lina Haddad, Peter Novak, Chloe Martin, Samuel Osei, Thomas Miller*
Applications of the Biopharmaceutics Classification System
Farah Aziz, Noah Miller, Khalid Mahmoud, Nur Hassan*
Patient Adherence to Medications in Chronic Diseases
Rina Prasetyo, George Papadopoulos, Ayesha Malik, Victor Hernandez, Khaled Mansour*
Overview of Drug Regulatory Approval Processes
Olivia White, Mustafa Kaya, Natalie Green, Aisha Rahman*, Helena Costa
